Alnylam Pharmaceuticals (ALNY) Land & Improvements (2016 - 2018)

Alnylam Pharmaceuticals (ALNY) has 3 years of Land & Improvements data on file, last reported at $9.1 million in Q4 2018.

• Quarterly Land & Improvements changed 0.0% year-over-year to $9.1 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $9.1 million (changed 0.0% YoY) and the FY2018 annual result came in at $9.1 million, changed 0.0% from the prior year.
• Land & Improvements steadied at $9.1 million in Q4 2018, from $9.1 million in the prior quarter.
• In the past five years, Land & Improvements ranged from a high of $9.1 million in Q4 2016 to a low of $9.1 million in Q4 2016.
• A 3-year average of $9.1 million and a median of $9.1 million in 2016 frame the typical range for Land & Improvements.
• The widest YoY moves for Land & Improvements: up 0.0% in 2017, down 0.0% in 2017.
• Tracing ALNY's Land & Improvements over 3 years: stood at $9.1 million in 2016, then changed by 0.0% to $9.1 million in 2017, then changed by 0.0% to $9.1 million in 2018.
• The last three Land & Improvements figures came in at $9.1 million (Q4 2018), $9.1 million (Q4 2017), and $9.1 million (Q4 2016), per Business Quant data.